European Working Group for Breast Screening Pathology
Distinction of isolated tumour cells and micrometastasis in lymph nodes of breast cancer patients according to the new Tumour Node Metastasis (TNM) definitions

Cserni, G., I. Amendoeira, S. Bianchi, E. Chmielik, J. Degaetano, D. Faverly, P. Figueiredo, M. P. Foschini, D. Grabau, J. Jacquemier, H. Kaya, J. Kulka, M. Lacerda, I. Liepniece-Karele, J. M. Penuela, C. Quinn, P. Regitnig, A. Reiner-Concin, A. Sapino, P. J. van Diest, Z. Varga, V. Vezzosi, J. Wesseling, V. Zolota, E. Zozaya and C. A. Wells (2011).

Eur J Cancer 47(6): 887-894.

http://www.ncbi.nlm.nih.gov/pubmed/21168328

Isolated tumour cells and micrometastases represent two different staging categories and are often dealt with differently when identified in sentinel lymph nodes of breast cancer patients. The reproducibility of these categories was found to be suboptimal in several studies. The new edition of the TNM (Tumour Node Metastasis) is expected to improve the reproducibility of these categories. Fifty cases of possible low-volume nodal involvement were represented by one to four digital images and were analysed by members of the European Working Group for Breast Screening Pathology (EWGBSP). The kappa value for interobserver agreement of the pN (TNM) staging categories and of the isolated tumour cells category were 0.55 and 0.56 reflecting moderate reproducibility, and the kappa of the micrometastatic category (0.62) reflected substantial reproducibility. This is an improvement over the results gained on the basis of the previous edition of the TNM. Maximal adherence to the category definitions supplemented by explanatory texts in the staging manual should result in more homogeneous nodal staging of breast cancer.

Quality assurance guidelines for pathology in: European guidelines for quality assurance in breast cancer screening and diagnosis, Supplements.

 

Pathology update. Quality assurance guidelines for pathology. In: European guidelines for quality assurance in breast cancer screening and diagnosis, Supplements.

 

Wells, C. A., A. I, J. P. Bellocq, S. Bianchi, W. Boecker, B. Borisch, B. Bruun Rasmussen, G. M. Callagy, C. E., A. Cordoba, G. Cserni, T. Decker, J. DeGaetano, M. Drijkoningen, I. O. Ellis, D. R. Faverly, M. P. Foschini, S. Frković-Grazio, D. Grabau, P. Heikkilä, E. Iacovou, J. Jacquemier, H. Kaya, J. Kulka, M. Lacerda, I. Liepniece-Karele, J. Martinez-Penuela, C. M. Quinn, F. Rank, P. Regitnig, A. Reiner, A. Sapino, T. Tot, P. J. Van Diest, Z. Varga, J. Wesseling, V. Zolota and E. Zozaya-Alvarez (2013).

Perry, M. Broeders, C. de Wolf et al. Luxembourg, European Commission, Office for Official Publications of the European Union.

 

DOWNLOAD HERE

Pathology update. Quality assurance guidelines for pathology. In: European guidelines for quality assurance in breast cancer screening and diagnosis, Supplements!

 

Pathology update. Quality assurance guidelines for pathology. In: European guidelines for quality assurance in breast cancer screening and diagnosis, Supplements.

 

Wells, C. A., A. I, J. P. Bellocq, S. Bianchi, W. Boecker, B. Borisch, B. Bruun Rasmussen, G. M. Callagy, C. E., A. Cordoba, G. Cserni, T. Decker, J. DeGaetano, M. Drijkoningen, I. O. Ellis, D. R. Faverly, M. P. Foschini, S. Frković-Grazio, D. Grabau, P. Heikkilä, E. Iacovou, J. Jacquemier, H. Kaya, J. Kulka, M. Lacerda, I. Liepniece-Karele, J. Martinez-Penuela, C. M. Quinn, F. Rank, P. Regitnig, A. Reiner, A. Sapino, T. Tot, P. J. Van Diest, Z. Varga, J. Wesseling, V. Zolota and E. Zozaya-Alvarez (2013).

  1. Perry, M. Broeders, C. de Wolf et al. Luxembourg, European Commission, Office for Official Publications of the European Union.

DOWNLOAD HERE

image
image
image
image
image
image
image
image